Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
17 Giugno 2024 - 10:00PM
Business Wire
Quanterix Corporation (NASDAQ: QTRX), a company fueling
scientific discovery through ultrasensitive biomarker detection,
today announced that Chief Executive Officer, Masoud Toloue, and
Chief Financial Officer, Vandana Sriram, will attend the Scotiabank
Healthcare 1x1 Day on June 20, 2024.
To learn more about Quanterix, visit www.quanterix.com/company.
To learn more about Quanterix’s Simoa® technology, visit
www.quanterix.com/simoa-technology.
About Quanterix
From discovery to diagnostics, Quanterix’s ultrasensitive
biomarker detection is fueling breakthroughs only made possible
through its unparalleled sensitivity and flexibility. The Company’s
Simoa ® technology has delivered the gold standard for earlier
biomarker detection in blood, serum or plasma, with the ability to
quantify proteins that are far lower than the Level of
Quantification (LoQ). Its industry-leading precision instruments,
digital immunoassay technology and CLIA-certified Accelerator
laboratory have supported research that advances disease
understanding and management in neurology, oncology, immunology,
cardiology and infectious disease. Quanterix has been a trusted
partner of the scientific community for nearly two decades,
powering research published in more than 2,900 peer-reviewed
journals. Find additional information about the Billerica,
Massachusetts-based company at https://www.quanterix.com or follow
us on Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240617525411/en/
Media Contact: PAN Communications Maya Nimnicht
510-334-6273 quanterix@pancomm.com
Investor Relations Contact: Quanterix Francis Pruell
(508)-789-1725 ir@quanterix.com
Grafico Azioni Quanterix (NASDAQ:QTRX)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Quanterix (NASDAQ:QTRX)
Storico
Da Gen 2024 a Gen 2025
